Al's Comment:

 The Optune Open Houses were popular before the pandemic and they are now coming back, starting in Depew, NY.   It is a free dinner meeting where people who are using (or thinking of using) Optune can get together to share their experiances with each other and to learn about Optune.  


Posted on: 04/11/2023

Meet actual users and caregivers at an

Optune® Open House

Sign up and become a part of the GBM community

You’ll learn more about Optune, an FDA-approved treatment for GBM. Optune users and caregivers* will discuss

their experiences living with GBM and integrating Optune into their lives.

You will also have an opportunity to ask questions and discuss other topics about Optune.

* Dependent on availability.

THIS EVENT IS FOR PEOPLE WITH GBM AND THEIR CAREGIVERS.

Event details

Date: 5/11/2023

Time: 6:30 PM

Location: Italian Prime at Salvatore’s, 6461 Transit Road, Depew, NY 14043

Register today

Contact: Sharon Semler – Novocure, Inc

Call: 610-762-6474

E-mail: SSemler@Novocure.com

RSVP by: 5/9/2023

 

 

What is Optune® approved to treat?

Optune is a wearable, portable, FDA-approved device indicated to treat a type of brain cancer called

glioblastoma multiforme (GBM) in adult patients 22 years of age or older.

Newly diagnosed GBM

If you have newly diagnosed GBM, Optune is used together with a chemotherapy called temozolomide

(TMZ) if:

• Your cancer is confirmed by your healthcare professional AND

• You have had surgery to remove as much of the tumor as possible

Recurrent GBM

If your tumor has come back, Optune can be used alone as an alternative to standard medical therapy if:

• You have tried surgery and radiation and they did not work or are no longer working AND

• You have tried chemotherapy and your GBM has been confirmed by your healthcare professional

Who should not use Optune?

Optune is not for everyone. Talk to your doctor if you have:

An implanted medical device (programmable shunt), skull defect (missing bone with no replacement),

or bullet fragment. Optune has not been tested in people with implanted electronic devices, which may

cause the devices not to work properly, and Optune has not been tested in people with skull defects or

bullet fragments, which may cause Optune not to work properly

A known sensitivity to conductive hydrogels (the gel on the arrays placed on the scalp like the ones used

on EKGs). When Optune comes into contact with the skin, it may cause more redness and itching or may

rarely cause a life-threatening allergic reaction

Do not use Optune if you are pregnant or are planning to become pregnant. It is not known if Optune is

safe or effective during pregnancy.

What should I know before using Optune?

Optune should only be used after receiving training from qualified personnel, such as your doctor, a nurse,

or other medical staff who have completed a training course given by Novocure®, the maker of Optune.

• Do not use any parts that did not come with the Optune Treatment Kit sent to you by Novocure or given to

you by your doctor

• Do not get the device or transducer arrays wet

• If you have an underlying serious skin condition on the scalp, discuss with your doctor whether this may

prevent or temporarily interfere with Optune treatment

What are the possible side effects of Optune?

Most common side effects of Optune when used together with chemotherapy (temozolomide, or TMZ)

were low blood platelet count, nausea, constipation, vomiting, tiredness, scalp irritation from the device,

headache, seizure, and depression.

The most common side effects when using Optune alone were scalp irritation (redness and itchiness) and

headache. Other side effects were malaise, muscle twitching, fall and skin ulcers.

Talk to your doctor if you have any of these side effects or questions.

Please visit Optune.com/Safety for the Optune Patient Information and Operation Manual for complete

information regarding the device’s indications, contraindications, warnings, and precautions.

 


Click HERE to return to brain tumor news headlines.


Our privacy / cookie policy has changed.
Click HERE to read it!